Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Hermann

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Journal of Pharmacokinetics and Pharmacodynamics|March 10, 2018
Quantitative approach for cardiac risk assessment and interpretation in tuberculosis drug developmentSebastian Polak, Klaus Romero, Alexander Berg, et al.
Membranes|August 23, 2020
The Effects of Temperature and Humidity on the Microstructure of Sulfonated Syndiotactic-polystyrene Ionic MembranesMaria-Maddalena Schiavone, David Hermann Lamparelli, Yue Zhao, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|September 6, 2012
The effects of aldosterone synthase inhibition on aldosterone and cortisol in patients with hypertension: a phase II, randomized, double-blind, placebo-controlled, multicenter studyKarl Andersen, Daniel Hartman, Thomas Peppard, et al.
Optics Express|June 6, 2009
Continuously tunable devices based on electrical control of dual-frequency liquid crystal filled photonic bandgap fibersLara Scolari, Thomas Alkeskjold, Jesper Riishede, et al.
Nature Medicine|June 13, 2025
Strategies for shortening tuberculosis therapyVéronique A Dartois, Valerie Mizrahi, Radojka M Savic, et al.
The AAPS Journal|March 16, 2018
Towards Bridging Translational Gap in Cardiotoxicity Prediction: an Application of Progressive Cardiac Risk Assessment Strategy in TdP Risk Assessment of MoxifloxacinNikunjkumar Patel, Oliver Hatley, Alexander Berg, et al.
The AAPS Journal|December 16, 2005
Model-based development of gemcabene, a new lipid-altering agentJaap W Mandema, David Hermann, Wenping Wang, et al.
Trials|August 25, 2018
Evaluating the safety, tolerability, pharmacokinetics and efficacy of clofazimine in cryptosporidiosis (CRYPTOFAZ): study protocol for a randomized controlled trialPatrick Nachipo, David Hermann, Gerald Quinnan, et al.
Optics Express|June 3, 2009
All-optical modulation in dye-doped nematic liquid crystal photonic bandgap fibersThomas Alkeskjold, Jesper Lægsgaard, Anders Bjarklev, et al.
Antimicrobial Agents and Chemotherapy|December 29, 2025
A stochastic simulation-based approach to inform the relapsing mouse model study design for non-clinical assessment of tuberculosisJames Clary, Jessica K Roberts, Debra Hanna, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Journal of Pharmacokinetics and Pharmacodynamics|March 10, 2018
Quantitative approach for cardiac risk assessment and interpretation in tuberculosis drug developmentSebastian Polak, Klaus Romero, Alexander Berg, et al.
Membranes|August 23, 2020
The Effects of Temperature and Humidity on the Microstructure of Sulfonated Syndiotactic-polystyrene Ionic MembranesMaria-Maddalena Schiavone, David Hermann Lamparelli, Yue Zhao, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|September 6, 2012
The effects of aldosterone synthase inhibition on aldosterone and cortisol in patients with hypertension: a phase II, randomized, double-blind, placebo-controlled, multicenter studyKarl Andersen, Daniel Hartman, Thomas Peppard, et al.
Optics Express|June 6, 2009
Continuously tunable devices based on electrical control of dual-frequency liquid crystal filled photonic bandgap fibersLara Scolari, Thomas Alkeskjold, Jesper Riishede, et al.
Nature Medicine|June 13, 2025
Strategies for shortening tuberculosis therapyVéronique A Dartois, Valerie Mizrahi, Radojka M Savic, et al.
The AAPS Journal|March 16, 2018
Towards Bridging Translational Gap in Cardiotoxicity Prediction: an Application of Progressive Cardiac Risk Assessment Strategy in TdP Risk Assessment of MoxifloxacinNikunjkumar Patel, Oliver Hatley, Alexander Berg, et al.
The AAPS Journal|December 16, 2005
Model-based development of gemcabene, a new lipid-altering agentJaap W Mandema, David Hermann, Wenping Wang, et al.
Trials|August 25, 2018
Evaluating the safety, tolerability, pharmacokinetics and efficacy of clofazimine in cryptosporidiosis (CRYPTOFAZ): study protocol for a randomized controlled trialPatrick Nachipo, David Hermann, Gerald Quinnan, et al.
Optics Express|June 3, 2009
All-optical modulation in dye-doped nematic liquid crystal photonic bandgap fibersThomas Alkeskjold, Jesper Lægsgaard, Anders Bjarklev, et al.
Antimicrobial Agents and Chemotherapy|December 29, 2025
A stochastic simulation-based approach to inform the relapsing mouse model study design for non-clinical assessment of tuberculosisJames Clary, Jessica K Roberts, Debra Hanna, et al.
Pageof 4